Identifying priority areas to support primary care engagement in breast cancer survivorship care: A Delphi study

Cancer medicine

Published On 2024/5

IntroductionExisting approaches in cancer survivorship care delivery have proven to be insufficient to engage primary care. This study aimed to identify stakeholder-informed priorities to improve primary care engagement in breast cancer survivorship care.MethodsExperts in U.S. cancer survivorship care delivery were invited to participate in a 4-round online Delphi panel to identify and evaluate priorities for defining and fostering primary care's engagement in breast cancer survivorship. Panelists were asked to identify and then assess (ratings of 1-9) the importance and feasibility of priority items to support primary care engagement in survivorship. Panelists were asked to review the group results and reevaluate the importance and feasibility of each item, aiming to reach consensus.ResultsRespondent panelists (n = 23, response rate 57.5%) identified 31 priority items to support survivorship care. Panelists …

Journal

Cancer medicine

Volume

13

Issue

9

Page

e7219

Authors

Benjamin F Crabtree

Benjamin F Crabtree

Rutgers, The State University of New Jersey

H-Index

90

Research Interests

Primary Care Practice Change

Jeanne M. Ferrante, MD, MPH

Jeanne M. Ferrante, MD, MPH

Rutgers, The State University of New Jersey

H-Index

40

Research Interests

obesity

cancer

primary care

gut microbiome

health disparities

Denalee O'Malley

Denalee O'Malley

Rutgers, The State University of New Jersey

H-Index

12

Research Interests

cancer survivorship

health disparities

opiate use disorder

social work

implementation research

Other Articles from authors

Shawna Hudson

Shawna Hudson

Rutgers, The State University of New Jersey

Supportive Care in Cancer

Coverage for evidence-based cancer survivorship care services

PurposeThe American Society of Clinical Oncology Cancer Survivorship Committee established a task force to determine which survivorship care services were being denied by public and private payers for coverage and reimbursement.MethodsA quantitative survey instrument was developed to determine the clinical practice-reported rates of coverage denials for evidence-based cancer survivorship care services. Additionally, qualitative interviews were conducted to understand whether coverage denials were based on payer policies, cost-sharing, or prior authorization.ResultsOf 122 respondents from 50 states, respondents reported that coverage denials were common (“always,” “most of the time,” or “some of the time”) for maintenance therapies, screening for new primary cancers or cancer recurrence. Respondents reported that denials in coverage for maintenance therapies were highest for immunotherapy …

Benjamin F Crabtree

Benjamin F Crabtree

Rutgers, The State University of New Jersey

Frontiers in Medicine

Population health in primary care

Population health in the United States continues to lag behind other wealthy nations. Primary care has the promise of enhancing population health; however, the implementation of a population health approach within primary care deserves further consideration. Clinicians and staff from a national sample of 10 innovative primary care practices participated in a working conference to reflect upon population health approaches in primary care. A series of small- and large-group discussions were recorded, transcribed, and coded through an immersion/crystallization approach. Two prominent themes emerged: (1) Transitioning to a population health focus generally develops through stages, with early implementation focusing on risk stratification and later, more advanced stages focusing on community health; and (2) Several inherent barriers confront implementation of a population health approach, including tensions with patient-centered care, and limitations of health information technology. A broader conceptualization of population health in terms of community health could more effectively allow partnerships among primary care, large health care systems, public health organizations, patients, and other partners in the community.

Shawna Hudson

Shawna Hudson

Rutgers, The State University of New Jersey

Enhancing Capacity for Primary Care Research in Cancer Survivorship: A Workshop for Action

In collaboration with the NCI Office of Cancer Survivorship, Shawna Hudson co-chaired the virtual event,“Enhancing Capacity for Primary Care Research in Cancer Survivorship: A Workshop for Action,” to discuss research needs for addressing the intersection between primary care and cancer survivorship.

Denalee O'Malley

Denalee O'Malley

Rutgers, The State University of New Jersey

Mentoring and Team Building for Research Success

Denalee O’Malley participated on the panel “Mentoring and Team Building for Research Success” during virtual event,“Enhancing Capacity for Primary Care Research in Cancer Survivorship: A Workshop for Action.”

Benjamin F Crabtree

Benjamin F Crabtree

Rutgers, The State University of New Jersey

Australian Journal of Primary Health

Leading primary care under the weight of COVID-19: how leadership was enacted in six australian general practices during 2020.

Background The COVID-19 pandemic challenged healthcare delivery globally, providing unique challenges to primary care. Australia’s primary healthcare system (primarily general practices) was integral to the response. COVID-19 tested the ability of primary healthcare to respond to the greater urgency and magnitude than previous pandemics. Early reflections highlighted the critical role of leaders in helping organisations negotiate the pandemic’s consequences. This study explores how general practice leadership was enacted during 2020, highlighting how leadership attributes were implemented to support practice teams. Methodology We performed secondary analysis on data from a participatory prospective qualitative case study involving six general practices in Melbourne, Victoria between April 2020 and February 2021. The initial coding template based on Miller et al’s Relationship Centred Model …

Shawna Hudson

Shawna Hudson

Rutgers, The State University of New Jersey

New Jersey Healthcare Essential Worker Outreach and Education Study-Testing Overlooked Occupations (NJ HEROES TOO) project

Shawna Hudson and Reynold Panettieri presented the New Jersey Healthcare Essential Worker Outreach and Education Study-Testing Overlooked Occupations (NJ HEROES TOO) project to the RADxUp Governance Committee comprised of NIH senior leadership, including Institute and Center Directors.(The RADx-UP initiative is one of the most significant investments by the National Institutes of Health (NIH) in developing and implementing COVID-19 testing innovation and addressing health disparities. NJ HEROES TOO is one of 144 community-engaged research projects)

Denalee O'Malley

Denalee O'Malley

Rutgers, The State University of New Jersey

Virtual facilitation best practices and research priorities: a scoping review

BackgroundFacilitation is an implementation strategy that supports the uptake of evidence-based practices. Recently, use of virtual facilitation (VF), or the application of facilitation using primarily video-based conferencing technologies, has become more common, especially since the COVID-19 pandemic. Thorough assessment of the literature on VF, however, is lacking. This scoping review aimed to identify and describe conceptual definitions of VF, evaluate the consistency of terminology, and recommend “best” practices for its use as an implementation strategy.MethodsWe conducted a scoping review to identify literature on VF following the PRISMA-ScR guidance. A search of PubMed, Embase, Web of Science, and CINAHL databases was conducted in June 2022 for English language articles published from January 2012 through May 2022 and repeated in May 2023 for articles published from January 2012 …

Shawna Hudson

Shawna Hudson

Rutgers, The State University of New Jersey

Translational behavioral medicine

Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal Pap test results in underserved urban women: A feasibility …

Challenges in ensuring adherence to colposcopy and follow-up recommendations, particularly within underserved communities, hinder the delivery of appropriate care. Informed by our established evidence-based program, we sought to assess the feasibility and acceptability of a novel cognitive-affective intervention delivered through a Chatbot interface, aimed to enhance colposcopy adherence within an urban inner-city population. We developed the evidence-based intervention, CervixChat, to address comprehension of colposcopy’s purpose, human papillomavirus (HPV) understanding, cancer-related fatalistic beliefs, procedural concerns, and disease progression, offered in both English and Spanish. Females aged 21–65, with colposcopy appointments at an urban OBGYN clinic, were invited to participate. Enrolled patients experienced real-time counseling messages tailored via a Chatbot-driven …

Shawna Hudson

Shawna Hudson

Rutgers, The State University of New Jersey

Survivorship panel during the the American Society of Preventive Oncology 48th annual meeting

On March 19, Shawna Hudson participated on a survivorship panel during the the American Society of Preventive Oncology 48th annual meeting in Chicago.

Jeanne M. Ferrante, MD, MPH

Jeanne M. Ferrante, MD, MPH

Rutgers, The State University of New Jersey

The TELEhealth Shared decision-making Coaching and Navigation in Primary carE (TELESCOPE) intervention: a study protocol for delivering shared decision-making for lung cancer …

BackgroundLung cancer screening (LCS) can reduce lung cancer mortality but has potential harms for patients. A shared decision-making (SDM) conversation about LCS is required by the Centers for Medicare & Medicaid Services (CMS) for LCS reimbursement. To overcome barriers to SDM in primary care, this protocol describes a telehealth decision coaching intervention for LCS in primary care clinics delivered by patient navigators. The objective of the study is to evaluate the effectiveness of the intervention and its implementation potential, compared with an enhanced usual care (EUC) arm.MethodsPatients (n= 420) of primary care clinicians (n= 120) are being recruited to a cluster randomized controlled trial. Clinicians are randomly assigned to 1) TELESCOPE intervention: prior to an upcoming non-acute clinic visit, patients participate in a telehealth decision coaching session about LCS delivered by trained patient navigators and nurse navigators place a low-dose CT scan (LDCT) order for each TELESCOPE patient wanting LCS, or 2) EUC: patients receive enhanced usual care from a clinician. Usual care is enhanced by providing clinicians in both arms with access to a Continuing Medical Education (CME) webinar about LCS and an LCS discussion guide. Patients complete surveys at baseline and 1-week after the scheduled clinic visit to assess quality of the SDM process. Re-navigation is attempted with TELESCOPE patients who have not completed the LDCT within 3 months. One month before being due for an annual screening, TELESCOPE patients whose initial LCS showed low-risk findings are randomly assigned to receive a …

Shawna Hudson

Shawna Hudson

Rutgers, The State University of New Jersey

Clinic and patient perspectives on a proposed mHealth intervention to improve colposcopy attendance.

BACKGROUNDCervical cancer disparities persist among urban, minoritized women due to infrequent screening and follow-up.

Jeanne M. Ferrante, MD, MPH

Jeanne M. Ferrante, MD, MPH

Rutgers, The State University of New Jersey

Western Journal of Emergency Medicine

Characteristics and Barriers of Emergency Department Patients Overdue for Cancer Screening

MethodsAdult ED patients eligible for at least one cancer screening based on US Preventive Serivces Task Force guidelines completed a web-based survey. We examined the association of demographic characteristics and having a personal physician with being overdue on screening using chi-square or the Fisher exact test for categorical variables and t-tests for continuous variables.ResultsOf 221 participants, 144 were eligible for colorectal, 96 for cervical, and 55 for breast cancer screening. Of eligible patients, 46%(25/55) were overdue for breast cancer screening, 43%(62/144) for colorectal, and 40%(38/96) for cervical cancer screening. There were no significant characteristics associated with breast cancer screening. Being overdue for cervical cancer screening was significantly more likely for patients who were of Asian race (P= 0.02), had less than a high school diploma (P= 0.01), and were without a routine …

Benjamin F Crabtree

Benjamin F Crabtree

Rutgers, The State University of New Jersey

Cancer Epidemiology, Biomarkers & Prevention

Abstract IA020: Adaptation of provider and staff targeted evidence-based interventions in safety-net settings to achieve equitable HPV vaccination

Implementation science, conducted through a health equity lens and participatory stakeholder-engaged approach, can inform how to best to adapt and sustain interventions within safety-net settings (e.g., federally qualified health centers, hospital-affiliated clinics, county health systems reaching medically underserved communities) to achieve long-term cancer health equity. The current challenge in implementation science and cancer health equity is not a lack of knowledge about what works for cancer prevention and control improvement, but how to integrate, adapt and sustain effective evidence-based strategies (EBS) and tools into local community and clinic contexts where they are needed most. As an example, HPV vaccination rates remain below target levels among adolescents in the United States, which is particularly concerning in medically underserved with persistent disparities in HPV-associated cancer …

Shawna Hudson

Shawna Hudson

Rutgers, The State University of New Jersey

Progress in community health partnerships: research, education, and action

Connect: Cultivating Academic-Community Partnerships to Address Our Communities' Complex Needs During Public Health Crises

Background:Black and Latino communities have been disproportionately impacted by COVID-19 and we sought to understand perceptions and attitudes in four heavily impacted NJ counties to develop and evaluate engagement strategies to enhance access to testing.Objective:To establish a successful academic/community partnership team during a public health emergency by building upon longstanding relationships and using principles from community engaged research.Methods:We present a case study illustrating multiple levels of engagement, showing how we successfully aligned expectations, developed a commitment of cooperation, and implemented a research study, with community-based and healthcare organizations at the center of community engagement and recruitment.Lessons Learned:This paper describes successful approaches to relationship building including information sharing and …

Denalee O'Malley

Denalee O'Malley

Rutgers, The State University of New Jersey

Interactive Journal of Medical Research

Strategies to Bridge Equitable Implementation of Telehealth

During the COVID-19 pandemic, the rapid scaling of telehealth limited the extent to which proactive planning for equitable implementation was possible. The deployment of telehealth will persist in the postpandemic era, given patient preferences, advances in technologies, growing acceptance of telehealth, and the potential to overcome barriers to serve populations with limited access to high-quality in-person care. However, aspects and unintended consequences of telehealth may leave some groups underserved or unserved, and corrective implementation plans that address equitable access will be needed. The purposes of this paper are to (1) describe equitable implementation in telehealth and (2) integrate an equity lens into actionable equitable implementation.

Denalee O'Malley

Denalee O'Malley

Rutgers, The State University of New Jersey

BMC Primary Care

Adapting and implementing breast cancer follow-up in primary care: protocol for a mixed methods hybrid type 1 effectiveness-implementation cluster randomized study

BackgroundAdvances in detection and treatment for breast cancer have led to an increase in the number of individuals managing significant late and long-term treatment effects. Primary care has a role in caring for patients with a history of cancer, yet there is little guidance on how to effectively implement survivorship care evidence into primary care delivery.MethodsThis protocol describes a multi-phase, mixed methods, stakeholder-driven research process that prioritizes actionable, evidence-based primary care improvements to enhance breast cancer survivorship care by integrating implementation and primary care transformation frameworks: the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework and the Practice Change Model (PCM). Informed by depth interviews and a four round Delphi panel with diverse stakeholders from primary care and oncology, we will implement and evaluate …

Other articles from Cancer medicine journal

Konstantinos (Kostas) K Tsilidis

Konstantinos (Kostas) K Tsilidis

University of Ioannina

Cancer Medicine

Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysis

Background Sedentary behaviours have been associated with increased risks of some common cancers in epidemiological studies; however, it is unclear if these associations are causal. Methods We used univariable and multivariable two‐sample Mendelian randomisation (MR) to examine potential causal relationships between sedentary behaviours and risks of breast, colorectal and prostate cancer. Genetic variants associated with self‐reported leisure television watching and computer use were identified from a recent genome‐wide association study (GWAS). Data related to cancer risk were obtained from cancer GWAS consortia. A series of sensitivity analyses were applied to examine the robustness of the results to the presence of confounding. Results A 1‐standard deviation (SD: 1.5 h/day) increment in hours of television watching increased risk of breast cancer (OR per 1‐SD: 1.15, 95% confidence …

Kenrick Ng

Kenrick Ng

University College London

Cancer Medicine

Statin use and mortality risk in Asian patients with prostate cancer receiving androgen deprivation therapy: A population‐based cohort study

Background This study aimed to examine the associations between the use of statins concurrent with androgen deprivation therapy (ADT) and the risks of mortality in Asian patients diagnosed with prostate cancer (PCa). Methods Adult patients (≥18 years old) diagnosed with PCa who were receiving any form of ADT and were being treated at public hospitals in Hong Kong from December 1999 to March 2021 were retrospectively identified, with follow‐up conducted until September 2021. Patients who had received medical castration for <180 days without subsequent bilateral orchidectomy, those who had used statins concurrently with ADT for <180 days, and those with missing baseline total cholesterol levels were excluded. Statin users were defined as individuals who had used statins for ≥180 days concurrent with ADT, while non‐users were those who had not used any statins. PCa‐related mortality was …

Todd Peterson

Todd Peterson

Vanderbilt University

Cancer Medicine

Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift

Background It has been shown that tumor microenvironment (TME) hydroxyapatite (HAP) is typically associated with many malignancies and plays a role in tumor progression and growth. Additionally, acidosis in the TME has been reported to play a key role in selecting for a more aggressive tumor phenotype, drug resistance and desensitization to immunotherapy for many types of cancers. TME‐HAP is an attractive target for tumor detection and treatment development since HAP is generally absent from normal soft tissue. We provide strong evidence that dissolution of hydroxyapatite (HAP) within the tumor microenvironment (TME‐HAP) using a novel therapeutic can be used to kill cancer cells both in vitro and in vivo with minimal adverse effects. Methods We developed an injectable cation exchange nano particulate sulfonated polystyrene solution (NSPS) that we engineered to dissolve TME‐HAP …

Jonathan Sussman

Jonathan Sussman

McMaster University

Cancer Medicine

Virtual follow‐up care among breast and prostate cancer patients during and beyond the COVID‐19 pandemic: Association with distress

Background The purpose of this study was to investigate associations between self‐reported distress (anxiety/depression) and satisfaction with and desire for virtual follow‐up (VFU) care among cancer patients during and beyond the COVID‐19 pandemic. Methods Breast and prostate cancer patients receiving VFU at an urban cancer centre in Toronto, Canada completed an online survey on their sociodemographic, clinical, and technology, characteristics and experience with and views on VFU. EQ5D‐5 L was used to assess distress. Statistical models adjusted for age, gender, education, income and Internet confidence. Results Of 352 participants, average age was 65 years, 48% were women,79% were within 5 years of treatment completion, 84% had college/university education and 74% were confident Internet users. Nearly, all (98%) had a virtual visit via phone and 22% had a virtual visit via video. The …

Benjamin F Crabtree

Benjamin F Crabtree

Rutgers, The State University of New Jersey

Cancer medicine

Identifying priority areas to support primary care engagement in breast cancer survivorship care: A Delphi study

IntroductionExisting approaches in cancer survivorship care delivery have proven to be insufficient to engage primary care. This study aimed to identify stakeholder-informed priorities to improve primary care engagement in breast cancer survivorship care.MethodsExperts in U.S. cancer survivorship care delivery were invited to participate in a 4-round online Delphi panel to identify and evaluate priorities for defining and fostering primary care's engagement in breast cancer survivorship. Panelists were asked to identify and then assess (ratings of 1-9) the importance and feasibility of priority items to support primary care engagement in survivorship. Panelists were asked to review the group results and reevaluate the importance and feasibility of each item, aiming to reach consensus.ResultsRespondent panelists (n = 23, response rate 57.5%) identified 31 priority items to support survivorship care. Panelists …

Kazuyuki Murase

Kazuyuki Murase

University of Fukui

Cancer Medicine

Notch signaling genes and CD8+ T‐cell dynamics: Their contribution to immune‐checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study

Background Aberrant Notch signaling pathway has been related with the tumorigenesis in head and neck region, involving oral cavity. Here, we report the correlation between mutations in the Notch signaling pathway and CD8+ T‐cell infiltration via PD‐L1, which lead to enhanced antitumor immunity and may target for immune‐checkpoint inhibitors (ICIs) therapy. Methods This retrospective study analyzed the results of immunohistochemical staining for PD‐L1 and CD8+ T‐cell infiltration in 10 patients and whole‐exome sequencing (WES) was conducted on five of these patients to identify frequently mutated genes. Results Four of 10 patients were positive for PD‐L1 and CD8+ T. By analyzing WES in three of these four patients, we notably identified the mutations of NOTCH1, FBXW7, and noncoding RNA intronic mutation in NOTCH2NLR in two of these three patients. This study may enable better selection of …

Brian Fisher

Brian Fisher

University of Pennsylvania

Cancer Medicine

Household income and health‐related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research

Objective Examine the influence of household income on health‐related quality of life (HRQOL) among children with newly diagnosed acute myeloid leukemia (AML). Design Secondary analysis of data prospectively collected from pediatric patients receiving treatment for AML at 14 hospitals across the United States. Exposure Household income was self‐reported on a demographic survey. The examined mediators included the acuity of presentation and treatment toxicity. Outcome Caregiver proxy reported assessment of patient HRQOL from the Peds QL 4.0 survey. Result Children with AML (n= 131) and caregivers were prospectively enrolled to complete PedsQL assessments. HRQOL scores were better for patients in the lowest versus highest income category (mean±SD: 76.0±14 household income< 25,000vs.59.9±17income≥ 75,000; adjusted mean difference: 11.2, 95% CI: 2.2–20.2). Seven percent of …

Liying Zhang, Ph.D

Liying Zhang, Ph.D

University of Toronto

Cancer Medicine

Referred molecular testing as a barrier to optimal treatment decision making in metastatic non‐small cell lung cancer: Experience at a tertiary academic institution in Canada

Background Molecular testing is critical to guiding treatment approaches in patients with metastatic non‐small cell lung cancer (mNSCLC), with testing delays adversely impacting the timeliness of treatment decisions. Here, we aimed to evaluate the time from initial mNSCLC diagnosis to treatment decision (TTD) following implementation of in‐house EGFR, ALK, and PD‐L1 testing at our institution. Methods We conducted a retrospective chart review of 165 patients (send‐out testing, n = 92; in‐house testing, n = 73) with newly diagnosed mNSCLC treated at our institution. Data were compared during the send‐out (March 2017–May 2019) and in‐house (July 2019–March 2021) testing periods. We performed a detailed workflow analysis to provide insight on the pre‐analytic, analytic, and post‐analytic intervals that constituted the total TTD. Results TTD was significantly shorter with in‐house testing (10 days …

Mirjam Sprangers

Mirjam Sprangers

Universiteit van Amsterdam

Cancer Medicine

Exploring resonance theory and uncontrollability during co‐creative art making: A qualitative study among cancer patients

Purpose Co‐creation, characterised by artists and patients creating a joint work of art, may support patients with the integration of life events, such as living with cancer, into their life story. In the process of co‐creation, resonance relationships between patients, artists and material may evolve that support such integration. Using the framework of resonance theory, we aim to investigate if and how patients move through the three phases of resonance during a process of co‐creation and explore the role of uncontrollability in this process. Methods Ten patients who received cancer treatment with palliative intent completed co‐creation processes, which were audio recorded. These recordings were imported in Atlas‐Ti and analysed by applying content analysis. We searched for the three phases of resonance, Being affected, touched and moved; Self‐efficacy and responding; Adaptive transformation. We additionally …

Mellissa Withers

Mellissa Withers

University of Southern California

Cancer Medicine

Global burden, risk factors, and trends of non‐Hodgkin lymphoma: A worldwide analysis of cancer registries

Background Non‐Hodgkin lymphoma (NHL) accounts for 90% of all malignant lymphomas. This study aimed to evaluate the global incidence, mortality, associated risk factors, and temporal trends of NHL by sex, age, and country. Methods Data from 185 countries globally were used for analysis. NHL incidence and mortality were collected via the GLOBOCAN (2020), CI5 series I‐X, WHO mortality database, the Nordic Cancer Registries, and the SEER Program. The WHO Global Health Observatory provided country‐level, age‐standardized prevalence of lifestyle and metabolic risk factors. Trends were examined and reported based on average annual percentage change (AAPC) calculated using Joinpoint regression analysis. Incidence and AAPC are based on data for the last 10 years across countries. Results Globally, age‐standardized incidence and mortality rates for NHL were recorded at 5.8 and 2.6 per …

Grant R. Williams

Grant R. Williams

University of Alabama at Birmingham

Cancer Medicine

Restricted life‐space mobility impacts physical but not mental quality of life in older cancer survivors

Background Older cancer survivors often value quality of life (QOL) over survival. Life‐space mobility (LSM), defined as the individual's spatial geographic mobility range, is an important QOL indicator in older adults with chronic illnesses; however, this relationship is unexplored in older cancer survivors. Methods We examined the longitudinal associations and causal relationships between LSM and QOL in 153 older cancer survivors (≥65 years) from the University of Alabama at Birmingham (UAB) Study of Aging. LSM was assessed using the UAB Life‐Space Assessment‐Composite score (LSA‐C), and QOL was assessed by the SF‐12 Mental Component Score (MCS12) and Physical Component Score (PCS12) at 0 (study entry), 6, 18, 36, 54, and 72 months. We examined the causal relationship between LSM and QOL using a cross‐lagged panel model (CLPM). Results The cohort (n = 153) was 76 …

Marilyn Hammer

Marilyn Hammer

Harvard University

Cancer Medicine

Common and distinct risk factors that influence more severe and distressing shortness of breath profiles in oncology outpatients

Background Shortness of breath occurs in 10%–70% of oncology patients. Very little is known about interindividual variability in its severity and distress and associated risk factors. Using latent profile analyses (LPAs), purpose was to identify subgroups of patients with distinct severity and distress profiles for shortness of breath as single symptom dimensions. In addition, a joint LPA was done using patients' severity AND distress ratings. For each of the three LPAs, differences among the shortness of breath classes in demographic, clinical, symptom, stress, and resilience characteristics were evaluated. Methods Patients completed ratings of severity and distress from shortness of breath a total of six times over two cycles of chemotherapy. All of the other measures were completed at enrollment (i.e., prior to the second or third cycle of chemotherapy). Separate LPAs were done using ratings of severity and distress, as …

Daniel Morgenstern

Daniel Morgenstern

University of Toronto

Cancer Medicine

Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada

Background The need for new therapies to improve survival and outcomes in pediatric oncology along with the lack of approval and accessible clinical trials has led to “out‐of‐trial” use of innovative therapies. We conducted a retrospective analysis of requests for innovative anticancer therapy in Canadian pediatric oncology tertiary centers for patients less than 30 years old between 2013 and 2020. Methods Innovative therapies were defined as cancer‐directed drugs used (a) off‐label, (b) unlicensed drugs being used outside the context of a clinical trial, or (c) approved drugs with limited evidence in pediatrics. We excluded cytotoxic chemotherapy, cellular products, and cytokines. Results We retrieved data on 352 innovative therapy drug requests. Underlying diagnosis was primary CNS tumor 31%; extracranial solid tumor 37%, leukemia/lymphoma 22%, LCH 2%, and plexiform neurofibroma 6%. RAS/MAP …

Rajesh Talluri

Rajesh Talluri

University of Mississippi Medical Center

Cancer medicine

Awareness and interest in cannabis use for cancer management among cancer survivors

Background We examined the awareness, interest, and information sources relating to cannabis use for cancer management (including management of cancer symptoms and treatment‐related side effects) and determined factors associated with cancer survivors' awareness and interest in learning about cannabis use for cancer management. Methods This was a cross‐sectional study of adult cancer survivors (N = 1886) receiving treatment at a comprehensive cancer center. Weighted prevalence and multivariable logistic regression analyses were conducted. Results Among cancer survivors, 88% were aware and 60% were interested in learning about cannabis use for cancer management. Common sources of information to learn about cannabis use for cancer management were cancer doctors/nurses (82%), other patients with cancer (27%), websites/blogs (26%), marijuana stores (20%), and family/friends …

Denalee O'Malley

Denalee O'Malley

Rutgers, The State University of New Jersey

Cancer medicine

Identifying priority areas to support primary care engagement in breast cancer survivorship care: A Delphi study

IntroductionExisting approaches in cancer survivorship care delivery have proven to be insufficient to engage primary care. This study aimed to identify stakeholder-informed priorities to improve primary care engagement in breast cancer survivorship care.MethodsExperts in U.S. cancer survivorship care delivery were invited to participate in a 4-round online Delphi panel to identify and evaluate priorities for defining and fostering primary care's engagement in breast cancer survivorship. Panelists were asked to identify and then assess (ratings of 1-9) the importance and feasibility of priority items to support primary care engagement in survivorship. Panelists were asked to review the group results and reevaluate the importance and feasibility of each item, aiming to reach consensus.ResultsRespondent panelists (n = 23, response rate 57.5%) identified 31 priority items to support survivorship care. Panelists …

Su-Hsin Chang

Su-Hsin Chang

Washington University in St. Louis

Cancer Medicine

Racial differences in treatment and survival among older patients with multiple myeloma

Background Treatments for multiple myeloma (MM) have evolved over time and improved MM survival. While racial differences in MM treatment and prognosis between non‐Hispanic African American (NHAA) and non‐Hispanic White (NHW) patients are well‐established, it is unclear whether they have persisted after the introduction of novel agents. Methods Using the Surveillance, Epidemiology, and End Results‐Medicare linked database, our study investigated racial difference in the receipt of treatment within 1 year following diagnosis and assessed survival outcomes among Medicare beneficiaries (≥66 years) diagnosed with MM from 2007 to 2017. We applied multivariable Cox proportional hazards models to estimate the association between race and survival and presented hazard ratios (HRs). Results Of 2094 NHAA and 11,983 NHW older patients with MM, 59.5% and 64.8% received treatment …

Peter Gardner

Peter Gardner

Manchester University

Cancer medicine

Prediction of prognosis in oral squamous cell carcinoma using infrared microspectroscopy

Background Estimation of prognosis of oral squamous cell carcinoma (OSCC) is inaccurate prior to surgery, only being effected following subsequent pathological analysis of the primary tumour and excised lymph nodes. Consequently, a proportion of patients are overtreated, with an increase in morbidity, or undertreated, with inadequate margins and risk of recurrence. We hypothesise that it is possible to accurately characterise clinical outcomes from infrared spectra arising from diagnostic biopsies. In this first step, we correlate survival with IR spectra derived from the primary tumour. Methods Infrared spectra were collected from tumour tissue from 29 patients with OSCC and subject to classification modelling. Results The model had a median AUROC of 0.89 with regard to prognosis, a median specificity of 0.83, and a hazard ratio of 6.29 in univariate Cox proportional hazard modelling. Conclusion The data …

Yuji Urabe

Yuji Urabe

Hiroshima University

Cancer Medicine

Clinicopathological and genomic features of superficial esophageal squamous cell carcinomas in nondrinker, nonsmoker females

Background Esophageal squamous cell carcinoma (ESCC) is sometimes detected in non‐drinker and non‐smoker females who are considered to have very low risk of ESCC development in daily practice. This study examined the clinicopathological and genomic characteristics of ESCCs in females with no history of drinking and smoking. Methods The sample comprised 118 ESCC lesions occurring in 95 female patients who underwent endoscopic submucosal dissection at our department between January 2008 and December 2019. The patients were categorized into two groups: 51 lesions in 49 patients with no history of drinking and smoking (nondrinker/nonsmoker [NDNS] group) and 69 lesions in 45 patients with a history of drinking or smoking (drinker/smoker [DS] group). We analyzed the differences in clinicopathological and cancerous genomic characteristics between the groups. Significant genomic …

Atsushi Masamune

Atsushi Masamune

Tohoku University

Cancer Medicine

Dickkopf 1 is expressed in normal fibroblasts during early stages of colorectal tumorigenesis

Background and Purpose Colorectal cancer progression from adenoma to cancer is a time‐intensive process; however, the interaction between normal fibroblasts (NFs) with early colorectal tumors, such as adenomas, remains unclear. Here, we analyzed the response of the microenvironment during early tumorigenesis using co‐cultures of organoids and NFs. Materials and Methods Colon normal epithelium, adenoma, cancer organoid, and NFs were established and co‐cultured using Transwell inserts. Microarray analysis of NFs was performed to identify factors expressed early in tumor growth. Immunostaining of clinical specimens was performed to localize the identified factor. Functional analysis was performed using HCT116 cells. Serum DKK1 levels were measured in patients with colorectal cancer and adenoma. Results Colorectal organoid–NF co‐culture resulted in increased organoid diameter and cell …

Lori Bernstein

Lori Bernstein

University of Toronto

Cancer Medicine

CaRE@ ELLICSR: Effects of a clinically integrated, group‐based, multidimensional cancer rehabilitation program

Background Although oncology clinical practice guidelines recognize the need and benefits of exercise, the implementation of these services into cancer care delivery remains limited. We developed and evaluated the impact of a clinically integrated 8‐week exercise and education program (CaRE@ELLICSR). Methods We conducted a mixed methods, prospective cohort study to examine the effects of the program. Each week, participants attended a 1‐h exercise class, followed by a 1.5‐h education session. Questionnaires, 6‐min walk tests (6MWT), and grip strength were completed at baseline (T0), 8 weeks (T1), and 20 weeks (T2). Semi‐structured interviews were conducted with a sub‐sample of participants about their experience with the program. Results Between September 2017 and February 2020, 277 patients enrolled in the program and 210 consented to participate in the research study. The mean …